The Lancet Regional Health Europe published an open-access analysis of 28 pull incentives, 20 of which have been implemented and eight of which are in development. AMR Action Fund’s Deepali Patel co-authored the analysis, which compared product and company eligibility and evaluation criteria across these incentives.
The authors wrote: Eligibility and evaluation criteria vary substantially across countries in scope and specificity. Company-level obligations on stewardship, access, and environmental safeguards are applied inconsistently, and most comprehensive in the UK and Swedish models. Greater international alignment around a shared core of criteria, while retaining flexibility for national context and operational feasibility, could reduce uncertainty for developers and strengthen the global incentive ecosystem.
Read the full The Lancet Regional Health Europe study here.